Home
 > search for

Featured Documents related to »  biotech pharma


Biopharma Contracts and Chargeback Systems: A Peek into the Market
Managing revenues, risk, and compliance is critical to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue

biotech pharma  to the survival of biotech and pharmaceutical companies (biopharma). But the complexity of revenue management in biopharma, such as contract and chargebacks, is not handled by ERP solutions. This article looks at contracts and chargeback systems functionality for biopharma and how that could help companies in other industries effectively manage their revenue streams. Read More...
ERP System Manufacturing of Pharmaceutical and Botanical Products
A U.S.-based biotechnology company was looking for a fully integrated enterprise resource planning (ERP) solution to replace its underused and overly complex legacy system. The new system would ...
Start evaluating software now
Country:

 Security code
Already have a TEC account? Sign in here.
 
Don't have a TEC account? Register here.

Documents related to » biotech pharma


The State of Global Clinical Research Trials
New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life sciences, and biotech sectors. Increased

biotech pharma  pharmaceuticals, life sciences, and biotech sectors. Increased global sales of life sciences products and growing demand for drugs present drug industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their research and development (R&D) expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials. Thanks to new technologies, the cloud, and social media/online portals, the pharmaceuticals, life Read More...
The Executive Guide to Contract and Chargeback Management
Life sciences companies are struggling to manage large group purchase organization (GPO) contracts, process chargeback submissions, and ensure that pricing

biotech pharma  average cost of a biotech product is $1.2 billion, according to reports by the Tufts Center for the Study of Drug Development (CSDD) . Given the enormous costs associated with getting a drug to market in the first place, manufacturers with patented drugs are under severe pressure to maximize profitability while they retain patent protections. Generic manufacturers, by contrast, must operate in an extremely efficient manner to drive profitability with far lower margins. Meanwhile, wholesaler demands on Read More...
A Portrait of the Enterprise Software User in the Pharmaceutical Industry
The pharmaceutical industry faces strict regulatory requirements in the approval of drugs for treatment of diseases. Software can help pharma successfully

biotech pharma  of smaller pharmaceutical and biotech firms, start-ups, medical research laboratories, and pharmaceutical service providers, some of which are likely supported by government grants and venture capital firms. Figure 2. Breakdown of Pharmaceutical Industry Users that Evaluated Enterprise Software in TEC Advisor by Company Size (as a percentage of all users). Top Software Types Enterprise resource planning (ERP) for SMBs topped the list of software types sought by software evaluators in the pharmaceutical Read More...
SaaS Buyer's Guide for Wholesale and Distribution
SaaS, despite its phenomenal popularity, is certainly not one-size-fits-all. You need to consider decision criteria such as fit, return on investment, and risk.

biotech pharma  human-insulin became the first biotech therapy to earn FDA approval, paving the way for increased acceleration in the industry's product development. Since 1992, the biotech industry has experienced an explosive growth; revenues from US publicly traded companies increased from $8 billion in 1992 to close to $59 billion in 2006, with research-intensive spending in excess of $27 billion. In today's competitive environment, healthcare products manufacturers are taking a hard look at capital requirements Read More...
Enterprise Contract Management for Life Sciences: Integrating Contract Creation, Administration, and Execution
Leading life sciences companies are recognizing the need for synchronized, enterprise-wide pricing and contract management processes. An integrated solution can

biotech pharma  shift toward biologics and biotech-pharma alliances. In addition, intermediary market influences are increasing the strength of traditional customers and expanding the involvement of payers and other new intermediaries. Leading life sciences companies are recognizing the need for synchronized, enterprise-wide pricing and contract management processes. An integrated solution can provide the transparency needed to satisfy auditors, balance pricing with go-to-market strategies, and support sales and finance Read More...
ERP System Manufacturing of Pharmaceutical and Botanical Products
A U.S.-based biotechnology company was looking for a fully integrated enterprise resource planning (ERP) solution to replace its underused and overly complex

biotech pharma  Company Profile Industry:   Biotech Annual Revenue Range:   $51 to $250 million Company Size:   101 to 250 employees Number of Sites:   1 site Approx. Num Of Users:   51–100 users Region:   North America (Canada and the United States) Project Profile 14  qualified bidders identified  RFIs issued Working list: Microsoft - Dynamics AX Deacom - Integrated Accounting and ERP Software Epicor - ERP 9 TGI - Enterprise 21 SAP - ByDesign SAP - All-in-One QAD - Enterprise Applications Oracle - JD Edwards Read More...
Taking Stock of TAKE Supply Chain Solutions - Part 1
Over the past several years I’ve repeatedly heard of a supply chain management (SCM) software and professional services company called ClearOrbit that was

biotech pharma   Read More...
4 Steps to a Best-run Business
To promote fast growth, small businesses often sacrifice process control for creativity. But sooner or later, unstructured creativity compounded by fast growth

biotech pharma  components Life sciences ' biotechnology and medical devices Mill products ' building materials and metal products Professional services ' IT and business process outsourcing services and facilities management Wholesale distribution ' technical goods wholesale distribution Reports and dashboards help you manage the business in real time, and there is built-in support for regulatory compliance, making it simple to address changing legal and reporting requirements for a global business. And you can now Read More...
Dassault Systèmes Rounds Out Process PLM Capabilities via Accelrys
Dassault Systèmes announced its intent to acquire Accelrys, Inc., a San Diego-based public provider of scientific innovation lifecycle management software for

biotech pharma  industry players in pharmaceutical, biotech, CPG, and chemicals including Sanofi, Pfizer, GSK, AstraZeneca, Du Pont, Shell, BASF, P&G, Unilever, and L’Oréal.   Accelrys offers high-end modeling tools for chemistry, which are very strong in life sciences and chemicals research. In late 2013, Accelrys bought QUMAS , a specialist in life sciences compliance and quality management software. It will be interesting to see how Dassault Systèmes will merge three quite different infrastructures ( Enginuity , Read More...
The Name and Ownership Change Roulette Wheel for Marcam Stops at SSA Global Part Three: Last-Ditch Effort by Invensys
Under Invensys, Marcam has seen things change frequently including reorganizations, management changes, strategy changes, and the loss of many employees with

biotech pharma  batch manufacturing software,manufacturing,manufacturing companies,manufacturing company,manufacturing pharmaceuticals,pharma software,pharmaceutical industry,pharmaceutical industry manufacturing,pharmaceutical manufacturing,pharmaceutical manufacturing equipment,pharmaceutical manufacturing software,pharmaceutical software,pharmacuetical companies,pharmacuetical company,pharmacuetical manufacturing systems Read More...
BI Principles for Another Kind of Intelligence
Traditional business intelligence (BI) and analytics applications aim to support the decision-making process of a company. By analyzing large amounts of data

biotech pharma   Read More...
Ross Systems - A Bright Spot On A Difficult Enterprise Application Landscape
Ross is among a very small group of vendors who have decided to build product exclusively for the process market. The resultant financial success should buy it

biotech pharma  life sciences (pharmaceutical and biotech), chemicals, forest products, and metals has been noteworthy. Ross has an installed base of over 3,000 enterprises utilizing its solution around the world. It has accomplished this by offering a broad and integrated product to the market through its iRenaissance suite of manufacturing, distribution and financial applications. This large install base gives it a foundation of economic strength due to the highly predictable software maintenance revenue associated Read More...

Recent Searches
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others